The North
America Drug Screening Market is projected to reach USD 6,852.8 Million by 2030
at 9.6% CAGR during the forecast period 2022-2030 .
The North
America drug screening market derives much
of its growth from the growing illicit use of drugs in the region and growing
awareness regarding the same. Rising prevalence of alcohol use disorder and illegal use of drugs provide impetus to the
North America drug screening market. Drug screening is a standard process in North America for acquiring jobs in airlines,
railways, government jobs and in places where public safety is involved which
boots the growth of the market. Businesses rely on drug testing of employees as
illicit drug use, or abuse can be
detrimental in the workplace. With various businesses
mandating drug screening in North America in an aim to increase productivity
and reduce medical costs, the North America drug screening market has been able
to flourish in the region. More schools in the US than ever before have
mandated drug screening of students as drug abuse by students has become a
common phenomenon. Drug screening of student
athletes too is permissible in North America. Furthermore, the U.S. Anti-Doping Agency (USADA) has strict
protocols pertaining to drug screening of
athletes participating in national and international sports which bolsters the
growth of the North America Drug Screening market. Misuse of prescription drugs
and alcohol is most likely in older people in North America which places a significant burden on the healthcare system.
Moreover, drug screening of older adults
to ascertain unknown drugs they have been using for a prolonged time. Legalization of recreational marijuana and the relaxation of state marijuana laws in North
America has reflected positively on the market growth. Stringent regulations
mandating drug screening is also a crucial driver. However, drug screening is
considered as a violation of privacy which is likely to hamper the
market growth over the forecast period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1507
Segmentation
The North
America drug screening market has been segmented
based on test sample and conditions. By test sample, the market has been segmented into Urine, Hair, Blood, and
Saliva. By condition, the market has been segmented into Unconsciousness, Chest
Pain, Panic Attack, Drug Allergies, and Others.
Regional
Analysis
The North
America drug screening market covers the US and Canada. These regions have
substantially high population bases who
are involved in drug abuse which drives the market. North America has
established stringent anti-doping regulations which support the drug screening
market. Moreover, development of drug and alcohol screening devices such as
organ-on-a-chip technology and rising disposable income in the region spurs the
growth of the market.
Competitive
Landscape
The key players
operating in the North America drug screening market include Siemens
Healthnieers, Quest Diagnostics, Thermo Fisher Scientific, Inc., Laboratory
Corporation of America Holdings, Roche Diagnostics, Express Diagnostics Int'l
Inc., Shimadzu Corporation, Alere Toxicology, and MPD.
Industry
Updates
In August 2018,
Bluechiip, a technology company, extended its existing agreement with Labcon
North America, to supply Labcon with chips and associated hardware necessary
for drug screening. The deal is worth USD 11.6 Million and will extend up to three years.
Browse
Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/north-america-drug-screening-market-1507
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New
York 10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments